May Ling Tham1, Aidalina Mahmud2, Rafidah Md Salleh1, Amirah Mohammad Razali1, Maha Abdullah3, Cheah Yoke Kqueen4, Muhammad Mohd Isa1*
1. Department of Ophthalmology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia
2. Department of Community Health, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia
3. Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia
4. Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia
*Corresponding author: Muhammad Mohd Isa.
ABSTRACT
INTRODUCTION: Seroconversion, indicated by the presence of antibodies after vaccination, varies between individuals. Using enzyme-linked immunosorbent assay (ELISA), individuals can be classified as high or low seroconverters based on their antibody levels. Understanding the molecular drivers of immune response variation is essential for enhancing immunization outcomes and achieving broad, effective protection.
OBJECTIVE(S): This study aimed to identify factors influencing seroconversion under healthy conditions by comparing transcriptomic profiles between high and low seroconverted healthcare workers in Hospital Sultan Abdul Aziz Shah (HSAAS), Universiti Putra Malaysia.
MATERIALS & METHODS: A group of healthcare workers who received two complete doses of Pfizer-BioNTech COVID-19 in 2021 were categorized as high or low seroconverters based on qualitative Wantai SARS-CoV-2 Ab ELISA results. Ten high and ten low seroconverters were recruited from this cohort study. Whole blood RNA was sequenced using the Illumina NovaSeq 6000 PE150 platform to investigate transcriptomic differences between high and low seroconverters.
RESULTS: A total of 175 genes were found to be differentially expressed in high seroconverters compared to low seroconverter at p-value <0.05. Among them, 63 genes were up-regulated (log2 fold change >1) and 112 genes were down-regulated (log2 fold change <1). Gene Ontology (GO) analysis revealed that these genes were significantly enriched in biological processes such as antibody-dependent cellular cytotoxicity (GO:0001788) (fold enrichment = 45.73, FDR = 0.022) and hypersensitivity (GO:0002524) (fold enrichment = 34.3, FDR = 0.045). Interestingly, an important enriched pathway identified in Kyoto Encyclopedia of Genes and Genomes database (KEGG) was Coronavirus disease- COVID-19 (hsa05171).
CONCLUSION: Understanding seroconversion variability is key to improve vaccine strategies, not only for COVID-19 but also as a reference model for other diseases. This preliminary study explores transcriptomic differences in healthy individuals to capture the basal immune state associated with seroconversion, offering insights that may enable early identification of low responders and guide personalized vaccination approaches.
KEYWORDS: Covid-19, Healthcare Workers, Seroconversion, ELISA, Transcriptomics


